The article A Deeper Look at Ketamine and its Potential for Addiction was originally published on Microdose. Ketamine might be the current poster child...
The article Small Pharma Expands IP With Another US Patent was originally published on Microdose. With the recent focus (and fuss) around patent protection...
The article Top 5 Psychedelic Clinical Trials in 2022 was originally published on Microdose. In order for psychedelic medicines to be legalized in a doctor-prescribed...
Mark Creasy-backed Azure Minerals (ASX:AZS) picks up lithium in rock chips grading up to 3.32% at Andover in the Pilbara. ... Read More The post Resources...
VANCOUVER, British Columbia, Oct. 18, 2022 (GLOBE NEWSWIRE) -- LOVE Pharma (CSE:LUV) (FSE:G1Q0) has provided an update on the launch of its psilocybin...
The article News You Might Have Missed: Oct 17th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
MindMed ($MNMD) – the starry-eyed prospect in the psychedelic biotech space has recently turned into a soap opera starring Freeman Capital, angry retail...
LOVE Pharma Co.(CSE:LUV | FSE:G1Q0), the Company is pleased to provide the following update on the advancement of the previously announced trial focused...
IntelGenx Corp. (IGX.TO) on Thursday provided an update on its collaboration with its strategic partner, Atai Life Sciences (atai) for the development...
The article Palo Santo Closes $50 Million Psychedelic Investment Fund was originally published on Microdose. Palo Santo Closes $50 Million Psychedelic...